Monitoring severe bacterial infections in hospitalized children
Observatory of Pediatric Severe Communautary Bacterial Infections
This study looks at how common and serious bacterial infections are in children in intensive care to help improve how these infections are treated and prevented.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 3000 (estimated) |
| Ages | N/A to 18 Years |
| Sex | All |
| Sponsor | Association Clinique Thérapeutique Infantile du val de Marne Academic / other |
| Locations | 1 site (Créteil) |
| Trial ID | NCT06260345 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the prevalence and characteristics of severe community-acquired invasive bacterial infections in children admitted to pediatric intensive care units. It will document clinical, biological, and microbiological data related to these infections, providing insights into their management. The study is crucial for understanding the epidemiology of these infections in France, where no current monitoring exists. By gathering this data, the study seeks to enhance prevention strategies for severe bacterial infections in hospitalized children.
Who should consider this trial
Good fit: Ideal candidates for this study are hospitalized children under 18 years old diagnosed with severe community-acquired bacterial infections.
Not a fit: Patients with nosocomial infections or those whose parents refuse participation will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved prevention and management strategies for severe bacterial infections in pediatric patients.
How similar studies have performed: While this study addresses a critical gap in monitoring, similar observational studies have shown success in understanding infection epidemiology in other populations.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age \<18 years (only hospitalized children) * Severe communautary bacterial infection defined by hospitalization in a pediatric intensive care unit (documentation of infection by identification of the bacteria in a sterile environment). Exclusion Criteria: * Refusal by one of the parents or by Child in understanding age * Nosocomial infection
Where this trial is running
Créteil
- Association Clinique Thérapeutique Infantile du val de Marne — Créteil, France (Recruiting)
Study contacts
- Principal investigator: Michael Levy — CHU Robert Debré, Paris
- Study coordinator: Corinne Levy
- Email: corinne.levy@activ-france.fr
- Phone: 1 48 85 04 04
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.